ImmPACT Bio USA Inc. Raises $18 Million In Series A Financing
Company is creating innovative cellular therapeutics for solid tumors
CAMARILLO, Calif., Aug. 18, 2020 -- (Healthcare Sales & Marketing Network) -- ImmPACT Bio USA Inc., a company founded in the FutuRx incubator located in Ness Ziona, Israel, developin... Biopharmaceuticals, Oncology, Venture Capital ImmPACT Bio USA, cell therapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Cancer & Oncology | Israel Health | Marketing | Middle East Health | Pharmaceuticals | Venture Capital